Home > Drug Search >
  • company_query: Acambis
  •   > 
Drug Filter
Category:
chemistry (3) biology (25)
Status:
Approved (6) NDA Filing (1) BLA Filing (2) Phase Ⅲ (5) Phase Ⅱ (7) Phase Ⅰ (7)
Clinical Stage:
Pending (3) Active (18) Discontinued (1)
Bio-Type:
Cell therapy (1) Vaccine (15) Recombinant enzyme (2) Recombinant coagulation factor (3) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Breast cancer (2) Crohn's disease (1) Cholera (1) Herpes simplex virus (1) Diarrhea (1) Anal cancer (1) Gastric cancer (1) Gaucher's disease (GD) (1) HBV infection (1) Melanoma (2) Motion sickness (1) Multiple myeloma (MM) (2) Myocardial infarction (MI) (1) Osteosarcoma (1) Pancreatic cancer (2) Prostate cancer (2) Psoriatic arthritis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Oropharyngeal cancer (1) Rectal fistula (1) Solid tumours (2) Chikungunya virus infections (1) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (1) Ankylosing Spondylitis (AS) (1) Biliary cancer (1) Cervical carcinoma (1) Hemophilia A (2) Hemophilia B (1) Esophagus cancer (1) Clostridial infection (1) Plaque psoriasis (1) Enterovirus infection (1) Dengue fever (1) Liver cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top